Article Details

Starton Therapeutics Completes One Third of STAR-LLD Study Enrollment - GlobeNewswire

Retrieved on: 2023-11-20 19:02:00

Tags for this article:

Click the tags to see associated articles and topics

Starton Therapeutics Completes One Third of STAR-LLD Study Enrollment - GlobeNewswire. View article details on hiswai:

Excerpt

PARAMUS, N.J., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up